AHR and hepatocellular carcinoma: Furthermore, in a mouse model of hepatocellular carcinoma, Kyn was shown to induce PD-1 upregulation in CD8+ T cells by activating the aryl hydrocarbon receptor (AhR), thereby evading immune killing and reducing the efficacy of immunotherapy (52).